l-Arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie’s fibrotic plaque and related fibroblast cultures
- 1 December 2003
- journal article
- Published by Elsevier in Nitric Oxide
- Vol. 9 (4) , 229-244
- https://doi.org/10.1016/j.niox.2003.12.002
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Peyronie's disease cell culture models: phenotypic, genotypic and functional analysesInternational Journal Of Impotence Research, 2002
- Gene expression in Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- L -Arginine effects on blood pressure and renal function of intrauterine restricted ratsPediatric Nephrology, 2002
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002
- Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosisCell and tissue research, 2002
- Human PDE5A gene encodes three PDE5 isoforms from two alternate promotersInternational Journal Of Impotence Research, 2002
- Cyclic nucleotide phosphodiesterasesJournal of Allergy and Clinical Immunology, 2001
- A RAT MODEL OF PEYRONIE’S DISEASE ASSOCIATED WITH A DECREASE IN ERECTILE ACTIVITY AND AN INCREASE IN INDUCIBLE NITRIC OXIDE SYNTHASE PROTEIN EXPRESSIONJournal of Urology, 2000
- Effects of Long-term Oral Administration of L-Arginine on the Rat Erectile ResponseJournal of Urology, 1997
- Nitric Oxide Donor SNAP Induces Apoptosis in Smooth Muscle Cells through cGMP-Independent MechanismBiochemical and Biophysical Research Communications, 1996